Triptolide improves chondrocyte proliferation and secretion via down-regulation of miR-221 in synovial cell exosomes

Phytomedicine. 2022 Dec:107:154479. doi: 10.1016/j.phymed.2022.154479. Epub 2022 Sep 29.

Abstract

Background: Rheumatoid arthritis (RA), the most common type of inflammatory arthritis, can cause bone damage and disability. Triptolide, a prominent treatment for RA, has satisfactory anti-inflammatory effects. However, the mechanism of action of triptolide in RA remains unknown.

Purpose: This study aimed to explore the molecular mechanisms underlying triptolide-mediated improvements in RA and identify the miRNA pathway responsible for these effects.

Methods: We identified various dysregulated miRNAs associated with RA by mining previously described microarray data and verified and screened these candidates using RT-qPCR. Hematoxylin-eosin staining was then applied to identify pathological changes in the affected joints, and cell counting kit-8 analysis and flow cytometry were employed to examine cell proliferation and apoptosis, respectively. Extracted exosomes were verified using transmission electron microscopy.

Results: Our results revealed that the legs of rats with collagen-induced arthritis presented with obvious swelling and bone damage, a high degree of inflammatory cell infiltration into the synovium, and structural changes to the cartilage. Data mining identified 39 dysregulated miRNAs in these tissues, and RT-qPCR further refined these observations to highlight miR-221 as a potential RA biomarker. Subsequent evaluations revealed that fibroblast-like synovial (FLS) cells secrete Exs carrying dysregulated miR-221 in vitro. These Exs mediate miR-221 levels, inflammation, and TLR4/MyD88 signaling via their fusion with chondrocytes, leading to changes in chondrocyte growth and metabolic factor levels. Additionally, the addition of triptolide impaired miR-221 expression, cell proliferation, inflammatory factors, and the protein levels of TLR4/MyD88 in RA-FLS and promoted the apoptosis of FLS. The therapeutic effect of triptolide on miR-221 Exs was reversed by miR-221 inhibitor in both normal and RA FLS.

Conclusion: Our research shows that effective treatment with triptolide is mediated by its regulation of growth and secretory functions of chondrocytes via the inhibition of miR-221 secretion by FLS, providing a new target and natural medicinal candidate for future RA treatments.

Keywords: Rheumatoid arthritis; chondrocyte; exosomes; miR-221; triptolide.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Apoptosis
  • Arthritis, Rheumatoid* / drug therapy
  • Arthritis, Rheumatoid* / genetics
  • Arthritis, Rheumatoid* / metabolism
  • Cell Proliferation
  • Cells, Cultured
  • Chondrocytes / metabolism
  • Diterpenes
  • Down-Regulation
  • Eosine Yellowish-(YS) / metabolism
  • Eosine Yellowish-(YS) / pharmacology
  • Epoxy Compounds
  • Exosomes* / metabolism
  • Exosomes* / pathology
  • Fibroblasts / metabolism
  • Hematoxylin / metabolism
  • Hematoxylin / pharmacology
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Myeloid Differentiation Factor 88 / metabolism
  • Phenanthrenes
  • Rats
  • Synovial Membrane / pathology
  • Toll-Like Receptor 4 / metabolism

Substances

  • Anti-Inflammatory Agents
  • Diterpenes
  • Epoxy Compounds
  • MIRN221 microRNA, rat
  • MicroRNAs
  • Myeloid Differentiation Factor 88
  • Phenanthrenes
  • Toll-Like Receptor 4
  • triptolide
  • Eosine Yellowish-(YS)
  • Hematoxylin